190 related articles for article (PubMed ID: 17239297)
1. Gemcitabine/carboplatin in a modified 21-day administration schedule for advanced-stage non-small-cell lung cancer.
Yoshimura M; Imamura F; Ueno K; Uchida J
Clin Lung Cancer; 2006 Nov; 8(3):208-13. PubMed ID: 17239297
[TBL] [Abstract][Full Text] [Related]
2. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
[TBL] [Abstract][Full Text] [Related]
3. Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer.
Beniwal SK; Patel KM; Shukla S; Parikh BJ; Shah S; Patel A
Indian J Cancer; 2012; 49(2):202-8. PubMed ID: 23107971
[TBL] [Abstract][Full Text] [Related]
4. Phase II study of an alternate carboplatin and gemcitabine dosing schedule in advanced non-small-cell lung cancer.
Mott FE; Cable CT; Sharma N
Clin Lung Cancer; 2003 Nov; 5(3):174-6. PubMed ID: 14667273
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine/carboplatin in patients with metastatic non-small-cell lung cancer: phase II study of 28-day and 21-day schedules.
Obasaju CK; Ye Z; Bloss LP; Monberg MJ; Curiel RE
Clin Lung Cancer; 2005 Nov; 7(3):202-7. PubMed ID: 16354316
[TBL] [Abstract][Full Text] [Related]
7. Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
Hainsworth JD; Burris HA; Erland JB; Morrissey LH; Meluch AA; Kalman LA; Hon JK; Scullin DC; Smith SW; Greco FA
Cancer; 1999 Mar; 85(6):1269-76. PubMed ID: 10189131
[TBL] [Abstract][Full Text] [Related]
8. Gemcitabine/carboplatin in advanced non-small cell lung cancer.
Zatloukal P; Petruzelka L
Lung Cancer; 2002 Nov; 38 Suppl 2():S33-6. PubMed ID: 12431827
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.
Thomas P; Robinet G; Ferri-Dessens RM; Léna H; Gouva S; Vernejoux JM; Kleisbauer JP
Lung Cancer; 2002 May; 36(2):191-8. PubMed ID: 11955654
[TBL] [Abstract][Full Text] [Related]
10. A randomized phase II trial using two different treatment schedules of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
Masters GA; Argiris AE; Hahn EA; Beck JT; Rausch PG; Ye Z; Monberg MJ; Bloss LP; Curiel RE; Obasaju CK
J Thorac Oncol; 2006 Jan; 1(1):19-24. PubMed ID: 17409822
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of carboplatin and gemcitabine as adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: a report from the Central Japan Lung Study Group, CJLSG 0503 trial.
Usami N; Yokoi K; Hasegawa Y; Taniguchi H; Shindo J; Yamamoto M; Suzuki R; Imaizumi K; Kondo M; Shimokata K;
Int J Clin Oncol; 2010 Dec; 15(6):583-7. PubMed ID: 20714770
[TBL] [Abstract][Full Text] [Related]
12. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase II study comparing two schedules of the 21-day regimen of gemcitabine and carboplatin in advanced non-small cell lung cancer.
Surmont V; Aerts JG; van Klaveren RJ; Tournoy K; Tan KY; Vernhout RM; Schmitz PI; Legrand C; Hoogsteden HC; van Meerbeeck JP
Oncology; 2010; 78(3-4):267-70. PubMed ID: 20523087
[TBL] [Abstract][Full Text] [Related]
14. Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma: carboplatin and gemcitabine followed by paclitaxel.
Edelman MJ; Gandara DR; Lau DH; Lara P; Lauder IJ; Tracy D
Cancer; 2001 Jul; 92(1):146-52. PubMed ID: 11443620
[TBL] [Abstract][Full Text] [Related]
15. A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer.
López-Vivanco G; Fuente N; Barceló R; Rubio I; Muñoz A; Mañé JM; Pérez-Hoyos T; Viteri A; Ferreiro J
Int J Clin Pharmacol Res; 2003; 23(1):9-16. PubMed ID: 14621068
[TBL] [Abstract][Full Text] [Related]
16. A new cisplatin/gemcitabine schedule in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer: relationship between dose-intensity and efficacy. A phase II study.
Rossi D; Graziano F; Catalano V; Giordani P; Fedeli SL; Alessandroni P; Fedeli A; Dennetta D; Ugolini M; Catalano G
Anticancer Res; 2002; 22(5):3087-92. PubMed ID: 12530048
[TBL] [Abstract][Full Text] [Related]
17. A phase II study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA non-small cell lung cancer.
Sakurai R; Tomizawa Y; Yoshii A; Miura Y; Tsurumaki H; Kaira K; Sunaga N; Kawashima O; Hisada T; Yamada M; Saito R
Cancer Chemother Pharmacol; 2018 Jan; 81(1):103-109. PubMed ID: 29124327
[TBL] [Abstract][Full Text] [Related]
18. A randomized phase II trial of gemcitabine plus carboplatin: biweekly versus standard schedules in patients with advanced non-small cell lung cancer.
Hasegawa Y; Miura D; Kitamura C; Suzuki T; Kobayashi K; Sato N
Chemotherapy; 2013; 59(5):346-53. PubMed ID: 24821009
[TBL] [Abstract][Full Text] [Related]
19. Randomized phase II study of two schedules of carboplatin and gemcitabine for stage IIIB and IV advanced non-small cell lung cancer (JACCRO LC-01 study).
Imamura F; Nishio M; Noro R; Tsuboi M; Ikeda N; Inoue A; Ohsaki Y; Kimura Y; Nishino K; Uchida J; Horai T
Chemotherapy; 2011; 57(4):357-62. PubMed ID: 21912118
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
Zatloukal P; Petruzelka L; Zemanová M; Kolek V; Skricková J; Pesek M; Fojtů H; Grygárková I; Sixtová D; Roubec J; Horenková E; Havel L; Průsa P; Nováková L; Skácel T; Kůta M
Lung Cancer; 2003 Sep; 41(3):321-31. PubMed ID: 12928123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
